Ozan Pamir, CFO at 180 Life Sciences, shares insights on the challenges faced by CFOs in the biotech industry. He discusses the modern CFO profile, qualities sought in team members, and how to navigate challenging economic times. Pamir also shares his experiences in investment banking, corporate strategy, and overseeing mergers. The podcast explores the innovations of 180 Life Sciences, their focus on inflammatory conditions, equity deals, and raising capital. Pamir offers advice for CFOs starting out in life sciences and discusses the impact of economic developments on innovative companies.
